HTA and Market Access Programme Research
HTA Industry Performance Metrics Programme
The annual CIRS HTA Industry Performance Metrics Programme was established to accrue comparative data and information to understand and quantify the impact of HTA requirements on clinical development programmes and reimbursement timing and outcomes in different jurisdictions. This study is the first focused effort to benchmark the influence of HTA on the development of new medicines by following individual products and has been developed in partnership with the pharmaceutical industry.
- Detailed company-specific reports with trend analyses
- Industry Discussion Meeting
- Company visits for discussion of bespoke analyses